UBS Group
AFTR.WS

UBS Group’s AfterNext HealthTech Acquisition Corp Warrants AFTR.WS Stock Holding History

UBS Group’s Portfolio AFTR.WS Stock Details AFTR.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,000
Closed -$167 – 10192
2023
Q1 		$167 Buy
1,000
+517
+107% +$80 ﹤0.01% 9165
2022
Q4 		$39 Sell
483
-3,177
-87% -$317 ﹤0.01% 10504
2022
Q3 		$1K Buy
3,660
+1,416
+63% +$331 ﹤0.01% 10164
2022
Q2 		$0 Sell
2,244
-1,761
-44% -$609 ﹤0.01% 11335
2022
Q1 		$2K Buy
4,005
+950
+31% +$515 ﹤0.01% 9739
2021
Q4 		$2K Buy
+3,055
New +$2.5K ﹤0.01% 9878

Other funds holding AFTR.WS

SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
GAM
Gritstone Asset Management Bethesda, Maryland $93.6M AUM 11.18% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
RIA
RP Investment Advisors Toronto, Ontario, Canada $900K AUM 17.98% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

UBS Group's AFTR.WS Position: Q2 2023 in Review

UBS Group sold out of AfterNext HealthTech Acquisition Corp Warrants (AFTR.WS) in Q2 2023, closing a stake of 1,000 shares — an estimated $167 sold.

UBS Group first reported a position in AFTR.WS in Q4 2021 and held it in 6 quarters. The position peaked at $2K in Q1 2022. 21 funds tracked by Wall St. Rank hold AFTR.WS as of Q2 2023.

  • UBS Group reported no remaining AfterNext HealthTech Acquisition Corp Warrants position as of Q2 2023 after selling out during the quarter.
  • UBS Group sold 1,000 AfterNext HealthTech Acquisition Corp Warrants shares in Q2 2023, an estimated $167.
  • UBS Group first reported a position in AfterNext HealthTech Acquisition Corp Warrants in Q4 2021 and held it in 6 quarters.
  • UBS Group's AfterNext HealthTech Acquisition Corp Warrants position peaked at $2K in Q1 2022.
  • 21 funds tracked by Wall St. Rank held AfterNext HealthTech Acquisition Corp Warrants as of Q2 2023.

Based on UBS Group's 13F filing for Q2 2023, filed 11 Aug 2023.